Article: Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Endo Pharmaceuticals.

Endo to Acknowledge Infringement of Purdue Patents and Stop Selling Infringing Oxycodone Products by the End of 2006

STAMFORD, Conn., Aug. 28 /PRNewswire/ -- Purdue Pharma L.P. of Stamford, Connecticut and Endo Pharmaceuticals Inc. of Chadds Ford, Pennsylvania have agreed to end the patent infringement lawsuit between them now pending in the United States District Court for the Southern District of New York concerning certain Purdue Pharma patents on OxyContin(R) (oxycodone HCl controlled- release) Tablets ("OxyContin"). According to the agreement, Endo will stop selling infringing versions of OxyContin by the end of 2006. In exchange, Purdue Pharma will not ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!